Comparatively, chidamide treatment reduced relative mRNA levels of Shh, Ihh, Dhh, E-cadherin, and MMP-2 in HS683 glioma cells (Figure 7(b), P < 0.05). Here, CDH1 is linked to central nervous system cancer.